Cathie Wood Bought Just 3 Stocks On Monday; Here They Are
The aggressive growth instructor was picky with her purchases to kick off the new trading week.
Cathie Wood, the founder and CEO of Ark Invest, only made three stock purchases on Monday, despite the market's overall rise. These additions included Nvidia, SoFi Technologies, and Scribe Therapeutics.
Nvidia, the world's second most valuable company by market cap, saw a 4% drop amid controversy surrounding its CEO, Jensen Huang, and a potential Chinese spy connection. Despite this, Nvidia's stock is trading at a discounted rate with a forward valuation of just 11.2 times its projected fiscal year profit.
SoFi Technologies, a digital bank operator, rose on Monday. However, it has declined 41% over the past year, with concerns about potential risks from rising interest rates and the broader adoption of conventional banks. SoFi's growth in member count, revenue, and its competitive interest rates on savings accounts suggest potential for continued growth.
Scribe Therapeutics, a gene-editing stock in Ark's portfolio, experienced a 6% increase. Despite its recent 22% decline over the past year, Scribe's proprietary ELXR platform and a substantial cash reserve until early 2029 provide a long-term outlook for potential investors.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.